Model
Edge
Revance Therapeutics Inc.
0001660467
Filing Type
3
Filing Date
9/19/2017
Updated
9/20/17, 2:50 PM
Filing
3
Earnings Release
Exhibits
3
Initial Statement of Beneficial Ownership